Table 1 The number of innovative drugs and generic drugs during 2018–2022
From: Successes and challenges of China’s health care reform: a four-decade perspective spanning 1985—2023
Year | Innovative drugs | Generic drugs | ||
|---|---|---|---|---|
Clinic | Product | Clinic | Product/Market | |
2018 | – | – | 58 | 464 (P) |
2019 | – | – | 107 | 373 (P) |
2020 | 1096 | 20 | 41 | 722 (P) |
2021 | 1522 | 45 | 52 | 933 (M) |
2022 | 1615 | 18 | – | – |